# Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

> **NCT00005075** · PHASE3 · TERMINATED · sponsor: **EDAP Technomed**

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** high-intensity focused ultrasound ablation

## Key facts

- **NCT ID:** NCT00005075
- **Lead sponsor:** EDAP Technomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Why stopped:** Withdrawn because Ablatherm devices were not available anymore at trial centers
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005075, "Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00005075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*